Analgesic Effects of Low-dose S-ketamine in Major Spine Fusion Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

April 1, 2025

Study Completion Date

May 2, 2025

Conditions
S-ketaminePostoperative AnalgesiaSpine Fusion
Interventions
DRUG

S-ketamine

"After anesthesia induction, a bolus of 0.15 mg/kg S-ketamine is injected intravenously about 30 min before incision; this is followed by a continuous infusion at a rate of 0.15 mg/kg/h until 1 hour before the end of surgery.~After surgery, patient-controlled analgesia is provided. The pump is established with S-ketamine 25 mg, dexmedetomidine 100 microgram, and sufentanil 100 microgram, diluted with normal saline to 100 ml. The pump is programmed to deliver 2-ml boluses with a background infusion rate at 1 ml /h and a 10-min lockout interval."

DRUG

Placebo

"After anesthesia induction, a bolus of placebo (normal saline) in the same volume is injected intravenously about 30 min before incision; this is followed by a continuous infusion of placebo at the same rate until 1 hour before the end of surgery.~After surgery, patient-controlled analgesia is provided. The pump is established with placebo, dexmedetomidine 100 microgram and sufentanil 100 microgram, diluted with normal saline to 100 ml. The pump is programmed to deliver 2-ml boluses with a background infusion rate at 1 ml /h and a 10-min lockout interval."

Trial Locations (1)

100034

Beijing University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER